James P. Zidar, MD

Commentary

Identifying the Vulnerable Plaque (IAGS Proceedings - Part I of II parts)

08/01/2008

Jim Zidar: We have chosen magnetic resonance imaging as our primary imaging tool at Duke University. A new cardiac magnetic resonance imaging research laboratory is being installed at Duke, with an adjacent clinical laboratory. In our view,...

Jim Zidar: We have chosen...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Temporal Trends in Target Vessel Revascularization in Clinical Practice: Long-Term Outcomes following Coronary Stenting
from th

08/01/2008

Robert H. Tuttle , MSPH;

James G. Jollis ;

David E. Kandzari , MD;

James P. Zidar , MD;

Randomized clinical trials evaluating coronary stents versus balloon angioplasty have demonstrated marked improvements in the short- and long-term safety and efficacy of percutaneous coronary intervention (PCI) by reducing restenosis and the...

Randomized clinical trials...

08/01/2008

Journal of Invasive Cardiology

Commentary

Identifying the Vulnerable Plaque (IAGS Proceedings - Part II of II)

08/01/2008

Klemens Barth , MD;

Mike Cowley , MD;

James P. Zidar , MD;

(IAGS Proceedings - Part II of II) Nick Hopkins: The preliminary reports on intracranial angioplasty and stenting showed very high morbidity and mortality rates associated with the procedure — particularly in symptomatic patients. As Dr....

(IAGS Proceedings - Part II of...

08/01/2008

Journal of Invasive Cardiology

Continuing Education

Pharmacoinvasive Management of Acute Coronary Syndrome:
Incorporating the 2007 ACC/AHA Guidelines

08/01/2008

Marc S. Cohen , MD;

Jose G. Diez , MD;

Sunil V. Rao , MD, FACC, FSCAI;

James J. Ferguson III, MD;

James P. Zidar , MD;

Glenn N. Levine , MD;

David A. Morrow , MD, MPH;

Every year, more than 1 million patients are admitted to a hospital with a diagnosis of unstable angina or non-ST-elevation myocardial infarction (UA/NSTEMI).1 Relative to acute ST-elevation myocardial infarction (STEMI), patients with...

Every year, more than 1 million...

08/01/2008

Journal of Invasive Cardiology

Commentary

2002 IAGS Proceedings: Intracranial Interventions (Part I of II)

08/01/2008

Douglas M. Cavaye , MD;

James P. Zidar , MD;

Max Amor , MD;

Michael Lawrence-Brown , MD;

John Anderson , DPM, FACFAS, MD;

John Anderson: In the U.S. and in Australia, stroke is the third leading cause of death and the leading cause of disability. Yet despite this, there is an air of therapeutic nihilism about stroke. Patients who present to the emergency room...

John Anderson: In the U.S. and...

08/01/2008

Journal of Invasive Cardiology

Continuing Education

Strategies for Optimizing Outcomes in the NSTE-ACS Patient: The CATH (Cardiac Catheterization and Antithrombotic Therapy
in th

08/01/2008

Edward T.A. Fry , MD;

Sunil V. Rao , MD, FACC, FSCAI;

James J. Ferguson III, MD;

James P. Zidar , MD;

Glenn N. Levine , MD;

Jacob Shani , MD;

Marc S. Cohen , MD;

Jose G. Diez , MD;

Target Audience: Clinical Cardiologists, Interventional Cardiologists and Nurses. Release Date: 12-01-06 Expiration Date: 11-30-07 Learning Objectives: Upon completion of this educational activity, participants should be able to: Educate...

Target Audience: Clinical...

08/01/2008

Journal of Invasive Cardiology

Commentary

2002 IAGS Proceedings: Intracranial Intervention (Part II of II)

08/01/2008

Douglas M. Cavaye , MD;

James P. Zidar , MD;

Max Amor , MD;

Michael Lawrence-Brown , MD;

John Anderson , DPM, FACFAS, MD;

Richard Myler: I have always believed that you don’t read history, you repeat it. You may never have heard about Richard Schneider who was the chief of Werner Forsmann in Germany. In 1929, a 24-year-old man who worked with Schneider had the...

Richard Myler: I have always...

08/01/2008

Journal of Invasive Cardiology

Continuing Education

Strategies for Optimizing Outcomes in the NSTE-ACS Patient: The CATH (Cardiac Catheterization and Antithrombotic Therapy
in th

08/01/2008

Marc S. Cohen , MD;

Jose G. Diez , MD;

Edward T.A. Fry , MD;

Sunil V. Rao , MD, FACC, FSCAI;

James J. Ferguson III, MD;

James P. Zidar , MD;

Glenn N. Levine , MD;

Jacob Shani , MD;

(PART II) A second group of patients who have received less attention were those who were switched at randomization; approximately three quarters of the patients were on some form of antithrombotic therapy prior to randomization — half of...

(PART II) A second group of...

08/01/2008

Journal of Invasive Cardiology

Commentary

Resolving Existing Restenosis

08/01/2008

James P. Zidar , MD;

Stefan Beyer-Enke ;

Peter Gonschior , MD;

Luis de la Fuente ;

Hal Whitworth ;

NULL

08/01/2008

Journal of Invasive Cardiology

Review

Pharmacoinvasive Management of Acute Coronary Syndrome in the Setting of Percutaneous Coronary Intervention: Evidence-Based, Sit

08/01/2008

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Gideon Bosker , MD;

Gary L. Schaer , MD, FACC, FSCAI;

Dean J. Kereiakes , MD, FACC, FSCAI;

Jose G. Diez , MD;

Edward T.A. Fry , MD;

James J. Ferguson III, MD;

James P. Zidar , MD;

Glenn N. Levine , MD;

James E. Tcheng , MD;

Over the past decade, impressive reductions in mortality, reinfarction and length of hospital stay have been reported in large-scale studies of patients with acute coronary syndrome (ACS). Despite these advances, substantial challenges remain...

Over the past decade, impressive...

08/01/2008

Journal of Invasive Cardiology